Topics

Glenmark and Lupin gain FDA approval for nervous system agents

04:49 EST 8 Nov 2019 | Generics and Biosimilars Initiative

Indian generics maker Glenmark Pharmaceuticals has been granted tentative US Food and Drug Administration (FDA) approval for its multiple sclerosis (MS) generic, while generics giant Lupin Ltd has also received FDA approval for its Dilantin generic, an anti-seizure medication.

Original Article: Glenmark and Lupin gain FDA approval for nervous system agents

NEXT ARTICLE

More From BioPortfolio on "Glenmark and Lupin gain FDA approval for nervous system agents"

Quick Search

Relevant Topic

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...